NewGenIVF lifts K25.ai stake to 13% in $7.5M deal to shore up Nasdaq compliance
What's the deal? NewGenIVF GroupDealroom has a profile for this one. Try Dealroom → has agreed to buy an additional 3% stake in AI-native livestreaming platform K25.aiDealroom has a profile for this one. Try Dealroom → for US$7.5 million, at a US$250 million valuation. The move lifts the Nasdaq-listed company's ownership from 10% to 13%, subject to customary closing conditions.
The terms: NewGen will pay in a mix of cash or digital assets plus 2.5 million newly issued Class A ordinary shares. The deal values NewGen's existing stake at US$25 million — more than double its original US$10 million cost.
Why now? The share issuance is expected to raise NewGen's outstanding shares to about 5.9 million and push its market capitalisation above US$5 million. That would bolster compliance with Nasdaq listing standards; the company's current market cap sits at $3.76 million.
What each side does: NewGen is a diversified group spanning real estate in Ras Al Khaimah, digital assets, health products, and a legacy IVF business across Asia. K25.ai blends live content, AI-assisted market creation, and interactive watch-to-predict experiences across sports, esports, and entertainment.
What's the endgame? NewGen frames the deal as deepening its exposure to an AI-driven information market platform, part of a broader growth strategy across Asia-Pacific and the Middle East. The company cited K25.ai's "strong community beta and accelerating user traction" as backing the higher valuation.
The signal: The transaction shows a small-cap issuer using a strategic AI stake — and its rising paper valuation — to reinforce its exchange standing. It also reflects how thinly capitalised firms are increasingly leaning on digital-asset payments and AI narratives to stay listed.
Read more: TipRanks
